E3 PreliminaryWeak / uncertainPEM unclearReview-NarrativePeer-reviewedMachine draft
Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.
Johnson, Andrew D, Cohn, Claudia S · Clinical microbiology reviews · 2016 · DOI
Quick Summary
In 2009, a virus called XMRV was found in some ME/CFS patients and created significant concern about blood safety. However, scientists later discovered that the virus actually came from contaminated laboratory samples, not from patients' actual infections. This paper explains how the virus was traced back to a laboratory mouse and why it turned out not to be a real threat to ME/CFS patients or blood donors.
Why It Matters
This study is important because it clarifies that XMRV is not associated with ME/CFS and was never a legitimate biological finding in patient samples. The resolution of the XMRV controversy demonstrates the importance of rigorous contamination controls in virology research and helps restore confidence in the scientific process when initial findings are contradicted by better evidence.
Observed Findings
- XMRV was detected in prostate cancer samples and subsequently in ME/CFS patient samples beginning in 2009.
- Molecular analysis traced XMRV to a single recombination event in a laboratory mouse around 1993.
- The virus spread through contamination of laboratory cell lines and research samples.
- Conflicting results emerged across different research groups regarding XMRV's disease association.
- Well-controlled experiments demonstrated that positive XMRV detections were artifacts of contamination, not genuine patient infections.
Inferred Conclusions
- XMRV detection in patient samples resulted from laboratory contamination rather than genuine viral infection in ME/CFS or prostate cancer patients.
- Rigorous contamination controls and independent replication are essential for validating novel virus discoveries in clinical samples.
- The blood donor deferral policy for CFS patients, based on XMRV concerns, was not justified by the underlying science.
Remaining Questions
- What other investigational leads in ME/CFS virology research have adequate contamination controls in place?
- How can the research community improve standardized protocols to prevent similar contamination events in the future?
What This Study Does Not Prove
This editorial does not prove that no pathogens are involved in ME/CFS pathophysiology—only that XMRV specifically is not one of them. It also does not establish whether other emerging viruses might play a role in ME/CFS, nor does it address other proposed infectious or non-infectious mechanisms of disease.
Tags
Method Flag:Exploratory Only
Metadata
- DOI
- 10.1128/CMR.00086-15
- PMID
- 27358491
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →